Mitofusin 2: The missing link between mtDNA maintenance defects and neurotransmitter disorders

Area of Science:

• Neurogenetics
• Mitochondrial Biology
• Biochemistry

Background:

• Mitofusin-2 (MFN2) is crucial for mitochondrial dynamics and is linked to Charcot-Marie-Tooth disease type 2A (CMT2A).
• MFN2 dysfunction is implicated in complex neurological disorders beyond CMT2A, suggesting broader roles in neuronal health.

Observation:

• A novel MFN2 pathogenic variant (p.Arg104Trp) was identified in an infant with early-onset chorea, severe axial hypotonia, and fluctuating dystonia.
• This infant presented a unique neurochemical profile characterized by secondary alterations in biogenic amine metabolism.

Findings:

• This is the first report linking the specific MFN2 p.Arg104Trp variant to a distinct neurochemical pattern involving biogenic amines.
• The findings suggest a connection between MFN2 function, mitochondrial health, and the regulation of neurotransmitter systems, particularly dopaminergic pathways.

Implications:

• This study expands the phenotypic spectrum associated with MFN2 variants, highlighting its role in early-onset movement disorders.
• Understanding the link between MFN2, mitochondrial dysfunction, and neurotransmitter alterations may offer new diagnostic and therapeutic insights for related neurological conditions.